Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT01682317

Healthy Eating Patterns During a Lifestyle Intervention

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
The University of Tennessee, Knoxville · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to address the gap in knowledge regarding the relationship between eating frequency and weight loss.

Detailed description

Little intervention research has been conducted to examine the influence of eating frequency (EF) on weight loss. It has been hypothesized an increased EF improves appetite control, assisting with better regulation of energy intake, thus decreasing body mass index. Unfortunately, outcomes have not shown greater appetite control with increased EF. Instead, trends favor a lower EF reducing energy intake thereby producing greater weight loss than a higher eating frequency. Thus, a lower eating frequency may lower energy intake via behavioral mechanisms. At thit time no research has examined the behavioral mechanisms that may mediate the relationship between a lower eating frequency and superior adherence to an energy-restricted diet.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEating FrequencyThirty adults will be provided an 8-week standard lifestyle intervention, that includes a 1200-1500 kcal/day, \< 30% energy from fat dietary prescription, and a physical activity goal of 200 minutes/week. Participants will be randomized to one of two conditions differing in EF using a prescription we have tested previously. One condition will limit the number of eating bouts/day to three (Three Meal), while the second condition will consume at least 100 kcal every 2 to 3 hours which should lead to approximately 6 eating bouts/day (Grazing).

Timeline

Start date
2012-08-01
Primary completion
2018-12-31
Completion
2025-12-31
First posted
2012-09-10
Last updated
2025-04-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01682317. Inclusion in this directory is not an endorsement.